KEYNOTE-590: Phase III study of first-line chemotherapy with or without pembrolizumab for advanced esophageal cancer

Kato, K; Shah, MA; Enzinger, P; Bennouna, J; Shen, L; Adenis, A; Sun, JM; Cho, BC; Ozguroglu, M; Kojima, T; Kostorov, V; Hierro, C; Zhu, Y; McLean, LA; Shah, S; Doi, T

Kato, K (reprint author), Natl Canc Ctr, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.

FUTURE ONCOLOGY, 2019; 15 (10): 1057

Abstract

Background: Treatment options for patients with advanced esophageal or esophagogastric junction (EGJ) cancer are limited. Current guidelines for first......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索